|
A
slow burn process
When caterpillars grow, they become butterflies. And when
an extremely popular Schedule K drug matures, it becomes OTC.
But it is not as simple as it sounds. Gauri Chaudhari, Brand
Consultant, FCB-Ulka Advertising points some finer points
of Rx to OTC switches to Nandini Patwardhan
Next
step in disposable processing
The biopharmaceutical industry has embraced disposable products
since their advent in the 1970's. First introduced for small
lab scale applications such as filtration, disposable products
have since become available for almost every aspect of biopharmaceutical
drug manufacturing.
'Win'ning
its way!
Focussing on in-licensing, Win-Medicare has adopted a strategy
that differentiates it from the crowd. Nandini Patwardhan
and Arshiya Khan find the long and short of it.
'Asia
Pacific is marked by high growth'
Patrick Brundage, Senior VP, Professional Services, marketRx
discusses why the company is a partner of choice for many
pharma and biotech companies with Arshiya Khan.
'SMEs
are silent drivers of economy'
Sanjeev Mantri, Joint General Manager and Head-Cluster Banking
Group of ICICI Bank talks to Katya Naidu on the bank's plans
for the pharma sector.
|
